These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 10657546

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis.
    Cerezo M, Laorden ML, Milanés MV.
    Eur J Pharmacol; 2002 Sep 27; 452(1):57-66. PubMed ID: 12323385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML, Castells MT, Martínez MD, Martínez PJ, Milanés MV.
    Endocrinology; 2000 Apr 27; 141(4):1366-76. PubMed ID: 10746640
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of morphine and U-50,488H on neurochemical activity of the hypothalamic noradrenergic neurons and pituitary-adrenal response.
    Laorden ML, Milanés MV.
    Neuropeptides; 1999 Apr 27; 33(2):131-5. PubMed ID: 10657482
    [Abstract] [Full Text] [Related]

  • 10. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
    Laorden ML, Milanés MV.
    Life Sci; 2000 Jan 21; 66(9):803-15. PubMed ID: 10698355
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance.
    Milanés MV, Puig MM, Vargas ML.
    Neuropeptides; 1993 May 21; 24(5):279-84. PubMed ID: 8327071
    [Abstract] [Full Text] [Related]

  • 12. CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.
    Navarro-Zaragoza J, Núñez C, Ruiz-Medina J, Laorden ML, Valverde O, Milanés MV.
    Br J Pharmacol; 2011 Feb 21; 162(4):851-62. PubMed ID: 20973778
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV, Laorden ML, Chapleur-Château M, Burlet A.
    J Pharmacol Exp Ther; 1998 May 21; 285(2):700-6. PubMed ID: 9580616
    [Abstract] [Full Text] [Related]

  • 18. The sigma ligand rimcazole activates noradrenergic neurons projecting to the paraventricular nucleus and increases corticosterone secretion in rats.
    Eaton MJ, Lookingland KJ, Moore KE.
    Brain Res; 1996 Sep 16; 733(2):162-6. PubMed ID: 8891298
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transgenerational blunting of morphine-induced corticosterone secretion is associated with dysregulated gene expression in male offspring.
    Vassoler FM, Toorie AM, Byrnes EM.
    Brain Res; 2018 Jan 15; 1679():19-25. PubMed ID: 29129606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.